ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 07/02/2020
Closing price: 265.12
Support price level: N/A
Resistance price level: $285.00
Relative strength index (14-day RSI) 39.8
Beta 0.89
  • BIIB is one of this month's worst performers with a return of -11.5%, underperforming 90 percent of stocks in the S&P-100.

  • Volatility is forecast to fall over the next month.

  • BIIB is below its 200-day moving average - additional caution warranted in long positions.

  • Price broke below prior support level - a short-term bearish signal.

Low High Price as % of Range
$217.44 $342.55 43.6%
200 day 50 day 20 day 10 day
$290.77 $293.75 $275.37 $264.56
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
39.6% 35.5% 37.8% 40.5%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 10.3% in the next week.

  • 22.9% in the next month.

  • 94.6% in the next year.